Literature DB >> 9444952

Contribution of enhanced transcriptional activation by ER to [12Val] K-Ras mediated NIH3T3 cell transformation.

K Kato1, Y Ueoka, K Kato1, T Hachiya, J Nishida, N Wake.   

Abstract

We investigated the biological significance of estrogen receptors (ER) in NIH3T3 cell transformation by the [12Val] K-Ras mutant. This mutant enhanced the steady state level of ER. Cells expressing mutant K-Ras (K12V cell) were tumorigenic. To determine the role of ER accumulation in Ras-transformed cells, we developed cells (KwtER cells) that overexpressed both wild-type (wt) K-Ras and ER, and found these cells were also tumorigenic. E2 stimulated the transcriptional activity by ER dominantly in K12V cells. However, only partial activation of ER by E2 was seen in KwtER cells. In the presence of 10% serum in media, the activation of ER appeared only in transformed KtwER and K12V cells, suggesting that two independently transmitted signals, the E2-ER binding and the ER-AF1 activation, are necessary for ER activation and that the dominant activation of ER might be involved in Ras-mediated cell transformation. Co-expression of progesterone receptor (PR) with mutant K-Ras led to suppression of tumorigenicity and inhibition of the activation of ER. The antisense oligomers complementary to the ER suppressed proliferation and transformed phenotypes of K12V cells. These observations support the importance of ER in Ras-mediated cell transformation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9444952     DOI: 10.1038/sj.onc.1201497

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  7 in total

1.  Pin1 modulates ERα levels in breast cancer through inhibition of phosphorylation-dependent ubiquitination and degradation.

Authors:  P Rajbhandari; K A Schalper; N M Solodin; S J Ellison-Zelski; K Ping Lu; D L Rimm; E T Alarid
Journal:  Oncogene       Date:  2013-04-01       Impact factor: 9.867

2.  Common variant on MDM2 contributes to endometrial cancer susceptibility: evidence based on 7 studies.

Authors:  Yan Zhao; Xiaoer Yang; Xiaojiao Hao; Xiaolin Pan; Bo Zhao; Jingwen Ma; Jian Fang; Minghong Zhao
Journal:  Tumour Biol       Date:  2014-05-03

3.  SNP55, a new functional polymorphism of MDM2-P2 promoter, contributes to allele-specific expression of MDM2 in endometrial cancers.

Authors:  Kanako Okamoto; Ryosuke Tsunematsu; Tomoko Tahira; Kenzo Sonoda; Kazuo Asanoma; Hiroshi Yagi; Tomoko Yoneda; Kenshi Hayashi; Norio Wake; Kiyoko Kato
Journal:  BMC Med Genet       Date:  2015-08-21       Impact factor: 2.103

4.  Association of MDM2 SNP309 and TP53 Arg72Pro polymorphisms with risk of endometrial cancer.

Authors:  Tomoko Yoneda; Ayumi Kuboyama; Kiyoko Kato; Tatsuhiro Ohgami; Kanako Okamoto; Toshiaki Saito; Norio Wake
Journal:  Oncol Rep       Date:  2013-04-29       Impact factor: 3.906

5.  K-Ras stabilization by estrogen via PKCδ is involved in endometrial tumorigenesis.

Authors:  Kyoung-Hwa Koo; Woo-Jeong Jeong; Yong-Hee Cho; Jong-Chan Park; Do Sik Min; Kang-Yell Choi
Journal:  Oncotarget       Date:  2015-08-28

6.  Sex-dependent development of Kras-induced anal squamous cell carcinoma in mice.

Authors:  Morgan T Walcheck; Kristina A Matkowskyj; Anne Turco; Simon Blaine-Sauer; Manabu Nukaya; Jessica Noel; Oline K Ronnekleiv; Sean M Ronnekleiv-Kelly
Journal:  PLoS One       Date:  2021-11-04       Impact factor: 3.240

7.  KRAS mutations: variable incidences in a Brazilian cohort of 8,234 metastatic colorectal cancer patients.

Authors:  Carlos Gil Ferreira; Veronica Aran; Ilana Zalcberg-Renault; Ana Paula Victorino; Jonas H Salem; Martin H Bonamino; Fernando M Vieira; Mariano Zalis
Journal:  BMC Gastroenterol       Date:  2014-04-10       Impact factor: 3.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.